EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in Nanoparticle Technologies for Prostate Cancer Detection and Therapy

Allayarov Abdullo, Yodgor Kenjaev, Ruzakhon Melibayeva, Ulmasov Firdavs, Nabieva Firuza iD, Abdulloyev Giyos

DNA and Cell Biology · 01.12.2026 · 45 (12) · 539-552

DOI: 10.1177/10445498261492508 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift DNA and Cell Biology, online erschienen am 01.11.2026. Verfasst von Allayarov Abdullo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maxillofacial Surgery, Andijan State Medical Institute, Andijan, Uzbekistan. Die Arbeit nennt 102 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) remains a significant global health challenge, necessitating innovative approaches for improved detection and treatment. Conventional methods often face limitations in specificity, sensitivity, and targeted drug delivery, leading to suboptimal outcomes and increased toxicity. Nanotechnology offers a promising avenue to overcome these hurdles, with nanoparticles (NPs) emerging as versatile tools for both diagnosing and treating PCa. This review explores recent advancements in nanoparticle technologies for PCa, focusing on their dual roles in early detection and targeted therapy. We highlight how the unique physicochemical properties of NPs enable enhanced drug loading, controlled release, and active targeting via specific ligands, thereby minimizing systemic toxicity and maximizing therapeutic efficacy. Furthermore, we discuss emerging applications of NPs as contrast agents for advanced imaging and as delivery vehicles for chemotherapeutics, gene therapies, and photothermal agents. Crucially, rather than merely describing preclinical progress, this review critically analyzes the significant bottlenecks in the translation of these nanoparticle-based theranostics from the laboratory to the clinical setting. By evaluating the challenges in scalable manufacturing, regulatory pathways, and long-term safety, we provide a comprehensive perspective on the steps required to realize the full clinical potential of nanomedicine in prostate cancer management.

Schlagwörter

Stichwörter der Autor:innen

detectionnanomedicinenanoparticlesprostate cancertherapy

Autor:innen und Institutionen

  • Department of Maxillofacial Surgery, Andijan State Medical Institute, Andijan, Uzbekistan.
  • Department of Basic Medical Sciences, Termez University of Economics and Service, Termez, Uzbekistan.
  • Department of Pedagogy and Psychology, Tashkent State Medical University, Tashkent, Uzbekistan.
  • Department of Oncology, Samarkand State Medical University, Samarkand, Uzbekistan.
  • Department of Oncology, Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan.
  • Department of Physics and Technological Education, Bukhara State Pedagogical Institute, Bukhara, Uzbekistan.

ORCID-Profile: Nabieva Firuza

Zitieren

APA

Abdullo, A., Kenjaev, Y., Melibayeva, R., Firdavs, U., Firuza, N., & Giyos, A. (2026). Advances in Nanoparticle Technologies for Prostate Cancer Detection and Therapy. DNA and Cell Biology, 45(12), 539-552. https://doi.org/10.1177/10445498261492508

Vancouver

Abdullo A, Kenjaev Y, Melibayeva R, Firdavs U, Firuza N, Giyos A. Advances in Nanoparticle Technologies for Prostate Cancer Detection and Therapy. DNA and Cell Biology. 2026;45(12):539-552. doi:10.1177/10445498261492508

BibTeX
@article{Abdullo2026,
  author = {Abdullo, Allayarov and Kenjaev, Yodgor and Melibayeva, Ruzakhon and Firdavs, Ulmasov and Firuza, Nabieva and Giyos, Abdulloyev},
  title = {Advances in Nanoparticle Technologies for Prostate Cancer Detection and Therapy},
  journal = {DNA and Cell Biology},
  year = {2026},
  volume = {45},
  number = {12},
  pages = {539--552},
  doi = {10.1177/10445498261492508}
}
Kostenlos starten →